Journal of NeuroVirology

, Volume 8, Issue 5, pp 381–391 | Cite as

Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system

  • Jayasri Das Sarma
  • Esther Scheen
  • Su-hun Seo
  • Michael Koval
  • Susan R. Weiss
Article

Abstract

Targeted recombination was used to select mouse hepatitis virus isolates with stable and efficient expression of the gene encoding the enhanced green fluorescent protein (EGFP). The EGFP gene was inserted into the murine coronavirus genome in place of the nonessential gene 4. These viruses expressed the EGFP gene from an mRNA of slightly slower electrophoretic mobility than mRNA 4. EGFP protein was detected on a Western blot of infected cell lysates and EGFP activity (fluorescence) was visualized by microscopy in infected cells and in viral plaques. Expression of EGFP remained stable through at least six passages in tissue culture and during acute infection in the mouse central nervous system. These viruses replicated with similar kinetics and to similar final extents as wild-type virus both in tissue culture and in the mouse central nervous system (CNS). They caused encephalitis and demyelination in animals as wild-type virus; however, they were somewhat attenuated in virulence. Isogenic EGFP-expressing viruses that differ only in the spike gene and express either the spike gene of the highly neurovirulent MHV-4 strain or the more weakly neurovirulent MHV-A59 strain were compared; the difference in virulence and patterns of spread of viral antigen reflected the differences between parental viruses expressing each of these spike genes. Thus, EGFP-expressing viruses will be useful in the studies of murine coronavirus pathogenesis in mice.

Keywords

murine coronavirus viral genetics viral pathogenesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bond CW, Leibowitz JL, Robb JA (1979). Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V. Virology 94: 371–384.CrossRefPubMedGoogle Scholar
  2. Cormack BP, Valdivia RH, Falkow S (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33–38.CrossRefPubMedGoogle Scholar
  3. Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E (2000). Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol 74: 9206–9213.CrossRefPubMedGoogle Scholar
  4. Fischer F, Stegen CF, Koetzner CA, Masters PS (1997). Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol 71: 5148–5160.PubMedGoogle Scholar
  5. Gombold JL, Hingley ST, Weiss SR (1993). Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol 67: 4504–4512.PubMedGoogle Scholar
  6. Gombold JL, Weiss SR (1992). Mouse hepatitis virus A59 increases steady state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathogen 13: 493–505.CrossRefGoogle Scholar
  7. Haas J, Park EC, Seed B (1996). Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 6: 315–324.CrossRefPubMedGoogle Scholar
  8. Houtman JJ, Fleming JO (1996). Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J NeuroVirol 2: 101–110.CrossRefPubMedGoogle Scholar
  9. Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ (2000). Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. J Virol 74: 1393–1406.CrossRefPubMedGoogle Scholar
  10. Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR (1984). Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34: 597–603.PubMedGoogle Scholar
  11. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MMC, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 62: 570–578.PubMedGoogle Scholar
  12. Leparc-Goffart I, Hingley ST, Chua MM, Jiang X, Lavi E, Weiss SR (1997). Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology 239: 1–10.CrossRefPubMedGoogle Scholar
  13. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR (1998). Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol 72: 9628–9636.PubMedGoogle Scholar
  14. Luytjes W, Bredenbeek PJ, Noten AF, Horzinek MC, Spaan WJM (1988). Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166: 415–422.CrossRefPubMedGoogle Scholar
  15. Matthews AE, Weiss SR, Shlomchik MJ, Hannum LG, Gombold JL, Paterson Y (2001). Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J Immunol 167: 5254–5263.PubMedGoogle Scholar
  16. Navas S, Seo SH, Chua MM, Sarma JD, Lavi E, Hingley ST, Weiss SR (2001). Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol 75: 2452–2457.CrossRefPubMedGoogle Scholar
  17. Ontiveros E, Kuo L, Masters PS, Perlman S (2001). Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 289: 230–238.CrossRefPubMedGoogle Scholar
  18. Phillips JJ, Chua MM, Lavi E, Weiss SR (1999). Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 73: 7752–7760.PubMedGoogle Scholar
  19. Phillips JJ, Chua M, Seo SH, Weiss SR (2001). Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence. J NeuroVirol 7: 421–431.CrossRefPubMedGoogle Scholar
  20. Sanger F, Nicklen S, Coulson AP (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467.CrossRefPubMedGoogle Scholar
  21. Schwarz B, Routledge E, Siddell SG (1990). Murine coronavirus nonstructural protein ns2 is not essential for virus replication in transformed cells. J Virol 64: 4784–4791.PubMedGoogle Scholar
  22. Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL (2001). Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 75: 2377–2387.CrossRefPubMedGoogle Scholar
  23. Smith BN, Banfield BW, Smeraski CA, Wilcox CL, Dudek FE, Enquist LW, Pickard GE (2000). Pseudorabies virus expressing enhanced green fluorescent protein: a tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits. Proc Natl Acad Sci USA 97: 9264–9269.CrossRefPubMedGoogle Scholar
  24. Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y (1997). CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J NeuroVirol 3: 225–228.CrossRefPubMedGoogle Scholar
  25. Yokomori K, Lai MMC (1991). Mouse hepatitis virus S sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J Virol 65: 5605–5608.PubMedGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2002

Authors and Affiliations

  • Jayasri Das Sarma
    • 1
  • Esther Scheen
    • 2
  • Su-hun Seo
    • 2
  • Michael Koval
    • 1
  • Susan R. Weiss
    • 2
  1. 1.Department of PhysiologyUniversity of Pennsylvania, School of MedicinePhiladelphiaUSA
  2. 2.Department of MicrobiologyUniversity of Pennsylvania, School of MedicinePhiladelphiaUSA

Personalised recommendations